Issues
-
Cover image
Cover Image
![issue cover]()
Cover: The Venus of Willendorf, a limestone figurine that is ∼11 cm high and dated 22,000-24,000 BC, was found in 1908 by the archaeologist Josef Szombathy near the town of Willendorf in Austria, and is now displayed in the Naturhistorisches Museum in Vienna. It is the most famous of a series of Upper Paleolithic Venus figurines found in middle Europe. Often described as mother goodness or as an amulet of fertility, it has also been heralded as the first example of obesity in human evolutionary history. Although it is unlikely that any human being who endured the fast and famines of the Paleolithic age would have had the chance to become obese, the figurine's enigmatic nature and round shape perfectly represent the mystery of why we are 'The obese species'. Image credit: Matthias Kabel; adapted under the GNU Free Documentation License.Close Modal - PDF Icon PDF LinkTable of contents
Foreword
In This Issue
Research Highlights
Editorial
Journal Club
Fasting, feasting and the glutamatergic synapse
Summary and comment on a recent Neuron paper entitled ‘Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone’ (Liu et al., 2012).
A Model For Life
Leading the charge in leptin research: an interview with Jeffrey Friedman
Jeffrey Friedman is a molecular geneticist whose group, in 1994, reported the long-sought identity and function of leptin (Zhang et al., 1994), a key fat-derived hormone that regulates feeding behaviour and body weight. This represented a massive step forward in our understanding of obesity, which is now one of the world’s fastest-growing health problems. Here, he recalls his journey of discovery and offers his perspective on the future of obesity research.
Obituary
Zofia Zukowska
The death of Zofia Zukowska, on April 15, 2012, represents the loss of a vibrant and energetic leader in the fields of stress physiology and neuropeptide Y (NPY) biology.
At A Glance
Special Article
Commentaries
Research Articles
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats
Research Reports
Virtual Meeting - Developmental Disorders: From Mechanism to Treatment
A collaboration between the Development and Disease Models & Mechanisms journal teams, this virtual Meeting will unite developmental biologists, human geneticists and clinical researchers to focus on building bridges from bench to clinic. Register your interest and find out more.
High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition
Vitamin B1 is shown to prevent nutrition-induced fatty liver in our current Editor’s choice by Hay Davir and his colleagues, when they use sheep as a large-animal model for studying the disease.
Find out more in an interview with the paper's first authors, Mugagga Kalyesubula and Ramgopal Mopuri.
Upcoming grant deadlines
Grants awarded by The Company of Biologists help scientists travel, attend events and host sustainable activities. Make a note of the upcoming application deadlines and find out more about the grants on offer:
DMM Conference Travel Grants
17 May 2021
Sustainable Conferencing Grants
17 May 2021
Travelling Fellowships
31 May 2021
Scientific Meeting Grants
4 June 2021
Call for papers - The RAS Pathway: Diseases, Therapeutics and Beyond
Our upcoming special issue is welcoming submissions until 3 May 2021. Guest-edited by Donita Brady (Perelman School of Medicine at the University of Pennsylvania, USA) and Arvin Dar (Icahn School of Medicine at Mount Sinai, USA), the issue will focus on targeting the RAS pathway.
